Improvement the Anti-migraine Treatment Efficacy by Tailoring the Drug to Individual's Pain Modulation Profile
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
- To delineate brain mechanisms that subserve endogenous analgesic (EA) in the healthy
state.
- To identify alterations in mechanisms supporting EA in chronic pain (migraine) and their
therapeutic relevance.